Literature DB >> 23684987

An inherently bifunctional subset of Foxp3+ T helper cells is controlled by the transcription factor eos.

Madhav D Sharma1, Lei Huang, Jeong-Hyeon Choi, Eun-Joon Lee, James M Wilson, Henrique Lemos, Fan Pan, Bruce R Blazar, Drew M Pardoll, Andrew L Mellor, Huidong Shi, David H Munn.   

Abstract

At sites of inflammation, certain regulatory T cells (Treg cells) can undergo rapid reprogramming into helper-like cells without loss of the transcription factor Foxp3. We show that reprogramming is controlled by downregulation of the transcription factor Eos (Ikzf4), an obligate corepressor for Foxp3. Reprogramming was restricted to a specific subset of "Eos-labile" Treg cells that was present in the thymus and identifiable by characteristic surface markers and DNA methylation. Mice made deficient in this subset became impaired in their ability to provide help for presentation of new antigens to naive T cells. Downregulation of Eos required the proinflammatory cytokine interleukin-6 (IL-6), and mice lacking IL-6 had impaired development and function of the Eos-labile subset. Conversely, the immunoregulatory enzyme IDO blocked loss of Eos and prevented the Eos-labile Treg cells from reprogramming. Thus, the Foxp3(+) lineage contains a committed subset of Treg cells capable of rapid conversion into biologically important helper cells.
Copyright © 2013 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23684987      PMCID: PMC3681093          DOI: 10.1016/j.immuni.2013.01.013

Source DB:  PubMed          Journal:  Immunity        ISSN: 1074-7613            Impact factor:   31.745


  37 in total

1.  Stability of the regulatory T cell lineage in vivo.

Authors:  Yuri P Rubtsov; Rachel E Niec; Steven Josefowicz; Li Li; Jaime Darce; Diane Mathis; Christophe Benoist; Alexander Y Rudensky
Journal:  Science       Date:  2010-09-24       Impact factor: 47.728

2.  Critical role of regulatory T cells in Th17-mediated minor antigen-disparate rejection.

Authors:  Benoît Vokaer; Nicolas Van Rompaey; Philippe H Lemaître; Frédéric Lhommé; Carole Kubjak; Fleur S Benghiat; Yoichiro Iwakura; Michel Petein; Kenneth A Field; Michel Goldman; Alain Le Moine; Louis-Marie Charbonnier
Journal:  J Immunol       Date:  2010-08-23       Impact factor: 5.422

3.  An interaction between kynurenine and the aryl hydrocarbon receptor can generate regulatory T cells.

Authors:  Joshua D Mezrich; John H Fechner; Xiaoji Zhang; Brian P Johnson; William J Burlingham; Christopher A Bradfield
Journal:  J Immunol       Date:  2010-08-18       Impact factor: 5.422

4.  Release of dendritic cells from cognate CD4+ T-cell recognition results in impaired peripheral tolerance and fatal cytotoxic T-cell mediated autoimmunity.

Authors:  Sabine Muth; Kristian Schütze; Hansjörg Schild; Hans Christian Probst
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-21       Impact factor: 11.205

5.  Cyclosporine-resistant, Rab27a-independent mobilization of intracellular preformed CD40 ligand mediates antigen-specific T cell help in vitro.

Authors:  Yoshinobu Koguchi; Jennifer L Gardell; Timothy J Thauland; David C Parker
Journal:  J Immunol       Date:  2011-06-15       Impact factor: 5.422

6.  Reprogrammed foxp3(+) regulatory T cells provide essential help to support cross-presentation and CD8(+) T cell priming in naive mice.

Authors:  Madhav D Sharma; De-Yan Hou; Babak Baban; Pandelakis A Koni; Yukai He; Phillip R Chandler; Bruce R Blazar; Andrew L Mellor; David H Munn
Journal:  Immunity       Date:  2010-12-09       Impact factor: 31.745

7.  Functional plasticity of antigen-specific regulatory T cells in context of tumor.

Authors:  Caroline Addey; Matthew White; Lang Dou; David Coe; Julian Dyson; Jian-Guo Chai
Journal:  J Immunol       Date:  2011-03-09       Impact factor: 5.422

8.  An intrinsic mechanism predisposes Foxp3-expressing regulatory T cells to Th2 conversion in vivo.

Authors:  Yunqi Wang; Abdallah Souabni; Richard A Flavell; Yisong Y Wan
Journal:  J Immunol       Date:  2010-10-13       Impact factor: 5.422

9.  Plasticity of Foxp3(+) T cells reflects promiscuous Foxp3 expression in conventional T cells but not reprogramming of regulatory T cells.

Authors:  Takahisa Miyao; Stefan Floess; Ruka Setoguchi; Hervé Luche; Hans Joerg Fehling; Herman Waldmann; Jochen Huehn; Shohei Hori
Journal:  Immunity       Date:  2012-02-09       Impact factor: 31.745

10.  Inflammation-driven reprogramming of CD4+ Foxp3+ regulatory T cells into pathogenic Th1/Th17 T effectors is abrogated by mTOR inhibition in vivo.

Authors:  Ekaterina Yurchenko; Marina T Shio; Tony C Huang; Maria Da Silva Martins; Moshe Szyf; Megan K Levings; Martin Olivier; Ciriaco A Piccirillo
Journal:  PLoS One       Date:  2012-04-24       Impact factor: 3.240

View more
  88 in total

Review 1.  Harnessing the plasticity of CD4(+) T cells to treat immune-mediated disease.

Authors:  Michel DuPage; Jeffrey A Bluestone
Journal:  Nat Rev Immunol       Date:  2016-02-15       Impact factor: 53.106

2.  MicroRNA-17 Modulates Regulatory T Cell Function by Targeting Co-regulators of the Foxp3 Transcription Factor.

Authors:  Huang-Yu Yang; Joseph Barbi; Chao-Yi Wu; Ying Zheng; Paolo D A Vignali; Xingmei Wu; Jin-Hui Tao; Benjamin V Park; Shashika Bandara; Lewis Novack; Xuhao Ni; Xiaoping Yang; Kwang-Yu Chang; Ren-Chin Wu; Junran Zhang; Chih-Wei Yang; Drew M Pardoll; Huabin Li; Fan Pan
Journal:  Immunity       Date:  2016-07-19       Impact factor: 31.745

3.  In Vitro Induction of Human Regulatory T Cells Using Conditions of Low Tryptophan Plus Kynurenines.

Authors:  K L Hippen; R S O'Connor; A M Lemire; A Saha; E A Hanse; N C Tennis; S C Merkel; A Kelekar; J L Riley; B L Levine; C H June; L A Turka; L S Kean; M L MacMillan; J S Miller; J E Wagner; D H Munn; B R Blazar
Journal:  Am J Transplant       Date:  2017-06-14       Impact factor: 8.086

Review 4.  Regulatory T cells in autoimmune disease.

Authors:  Margarita Dominguez-Villar; David A Hafler
Journal:  Nat Immunol       Date:  2018-06-20       Impact factor: 25.606

5.  Eos Is Redundant for Regulatory T Cell Function but Plays an Important Role in IL-2 and Th17 Production by CD4+ Conventional T Cells.

Authors:  Sadiye Amcaoglu Rieder; Amina Metidji; Deborah Dacek Glass; Angela M Thornton; Tohru Ikeda; Bruce A Morgan; Ethan M Shevach
Journal:  J Immunol       Date:  2015-06-10       Impact factor: 5.422

Review 6.  Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation.

Authors:  Cameron McDonald-Hyman; Laurence A Turka; Bruce R Blazar
Journal:  Sci Transl Med       Date:  2015-03-25       Impact factor: 17.956

7.  Age-dependent divergent effects of OX40L treatment on the development of diabetes in NOD mice.

Authors:  Christine S Haddad; Palash Bhattacharya; Khaled Alharshawi; Alejandra Marinelarena; Prabhakaran Kumar; Osama El-Sayed; Hatem A Elshabrawy; Alan L Epstein; Bellur S Prabhakar
Journal:  Autoimmunity       Date:  2016-05-31       Impact factor: 2.815

Review 8.  Ubiquitous points of control over regulatory T cells.

Authors:  Fan Pan; Joseph Barbi
Journal:  J Mol Med (Berl)       Date:  2014-04-29       Impact factor: 4.599

Review 9.  Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.

Authors:  Prabhakaran Kumar; Shikha Saini; Saad Khan; Swarali Surendra Lele; Bellur S Prabhakar
Journal:  Cell Immunol       Date:  2018-09-29       Impact factor: 4.868

10.  The immunotherapeutic role of regulatory T cells in Leishmania (Viannia) panamensis infection.

Authors:  Allison Ehrlich; Tiago Moreno Castilho; Karen Goldsmith-Pestana; Wook-Jin Chae; Alfred L M Bothwell; Tim Sparwasser; Diane McMahon-Pratt
Journal:  J Immunol       Date:  2014-08-06       Impact factor: 5.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.